Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder

NCT06521476 is registered in ClinicalTrials.gov with Sanjay R Patel as lead sponsor.

NCT NCT06521476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06521476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder
Lead sponsor
Sanjay R Patel
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2025
Completion date
February 29, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea comorbid with opioid use